Researchers at DZNE and the University Hospital Bonn, together with the Berlin-based company PeakProfiling GmbH, have developed a digital technology that recognizes the severity of speech…
New indicator for amyloid deposits discovered
Ulm/Halle, April 13, 2023 – Two characteristic pathologies of Alzheimer's disease are related: Deposits of amyloid beta peptide in the brain and…
Survey Underscores Interest in Exchange between Health Care Research and Practice
A survey among professionals from health care research and dementia care underlines the strong need for mutual…
Areas of investigation/research focus
My group is interested in defining key molecular pathways in the pathogenesis of neurodegeneration with a goal of identifying specific targets for therapeutic…
Research areas/focus
Similar to other diseases, also for neurocognitive disorders only a small portion of the research progress affects clinical practice. Hurdles are due to a variety of reasons,…
DZNE Lecture Award awarded to Prof. Stuart A. Lipton
On March 27, Prof. Stuart A. Lipton, MD, PhD was honoured at the DZNE in Bonn with the "DZNE Lecture Award". The DZNE thus honours scientists…
Clinical Trials Unit successfully certified
Following the Clinical Research Platform (CRP), the Clinical Trials Units (CTU) at the Center for Clinical Research in Bonn has now also been…
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
